HAMPSTEAD GROUP PRACTICE — All Prescriptions & Medications — Page 7
Practice Code: F83017 | LONDON, NW3 2QU
Showing results 301-350 of 679
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Ropinirole hydrochloride | 87 | 8,060 | £4.7K | -18.1% ▼ |
| Sodium fluoride | 87 | 8,986 | £590 | +162.2% ▲ |
| Urea | 87 | 38.5K | £1.4K | +30.2% ▲ |
| Betamethasone esters | 87 | 3,610 | £540 | +44.2% ▲ |
| Peppermint oil | 86 | 9,336 | £984 | +8.1% ▲ |
| 86 | 7,282 | £553 | -60.2% ▼ | |
| Naltrexone hydrochloride | 85 | 7,697 | £3.3K | +498.8% ▲ |
| Ursodeoxycholic acid | 84 | 9,367 | £3.1K | +26.9% ▲ |
| Phenytoin sodium | 84 | 6,118 | £1.2K | +4.0% ▲ |
| Terbinafine hydrochloride | 84 | 3,000 | £537 | +126.4% ▲ |
| Dutasteride | 82 | 4,232 | £251 | +59.7% ▲ |
| Benzoyl peroxide and clindamycin phosphate | 82 | 3,720 | £1.6K | +22.3% ▲ |
| Lidocaine hydrochloride | 82 | 1,796 | £1.6K | -52.5% ▼ |
| 82 | 1,871 | £986 | -19.7% ▼ | |
| 82 | 1,209 | £2.7K | +108.4% ▲ | |
| Lercanidipine hydrochloride | 81 | 3,100 | £352 | -86.9% ▼ |
| Zonisamide | 80 | 9,234 | £3.7K | +83.4% ▲ |
| Coal tar | 80 | 21.4K | £479 | +9.9% ▲ |
| Pioglitazone hydrochloride | 79 | 1,694 | £73 | -10.7% ▼ |
| 78 | 10.9K | £24.6K | +60.0% ▲ | |
| Prucalopride | 76 | 3,584 | £1.9K | +95.2% ▲ |
| Trazodone hydrochloride | 76 | 4,928 | £316 | -62.8% ▼ |
| Ciclosporin (Eye Anti Inflammatory) | 76 | 3,660 | £8.8K | +206.5% ▲ |
| 76 | 5,650 | £443 | +8.9% ▲ | |
| 75 | 9,100 | £283 | -42.8% ▼ | |
| 75 | 4,165 | £8.7K | +122.1% ▲ | |
| Vortioxetine | 74 | 2,912 | £2.7K | +6.6% ▲ |
| Rizatriptan | 74 | 741 | £2.6K | +24.5% ▲ |
| Flupentixol decanoate | 73 | 83 | £486 | +357.4% ▲ |
| Linagliptin | 73 | 2,151 | £2.4K | -82.2% ▼ |
| Bicalutamide | 73 | 3,755 | £258 | +125.6% ▲ |
| Leuprorelin acetate | 72 | 72 | £15.3K | +55.4% ▲ |
| Bimatoprost | 72 | 1,929 | £996 | -51.6% ▼ |
| Pramipexole | 71 | 3,510 | £1.6K | -27.7% ▼ |
| Biphasic isophane insulin | 71 | 468 | £2.0K | -36.4% ▼ |
| Tibolone | 71 | 3,612 | £335 | +132.0% ▲ |
| Etoricoxib | 71 | 3,189 | £719 | -11.9% ▼ |
| Sennosides | 70 | 31.1K | £579 | +126.7% ▲ |
| Biphasic insulin lispro | 70 | 415 | £2.6K | +63.0% ▲ |
| Azelastine hydrochloride | 70 | 1,988 | £905 | +524.5% ▲ |
| Valsartan | 69 | 4,228 | £1.5K | +17.1% ▲ |
| Hydrocortisone acetate | 69 | 2,310 | £441 | +4.5% ▲ |
| Travoprost | 67 | 283 | £422 | +42.2% ▲ |
| 67 | 3,940 | £4.7K | +80.5% ▲ | |
| Nizatidine | 66 | 3,212 | £3.1K | +91.8% ▲ |
| Medroxyprogesterone acetate | 66 | 71 | £413 | -45.3% ▼ |
| 66 | 284 | £2.1K | +112.8% ▲ | |
| 66 | 690 | £2.1K | +224.2% ▲ | |
| Flecainide acetate | 65 | 6,160 | £222 | -16.7% ▼ |
| Domperidone | 65 | 17.6K | £3.6K | +82.2% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.